These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 24123013)
1. In vitro induction of apoptosis and necrosis by new derivatives of daunorubicin. Stojak M; Mazur L; Opydo-Chanek M; Lukawska M; Oszczapowicz I Anticancer Res; 2013 Oct; 33(10):4439-43. PubMed ID: 24123013 [TBL] [Abstract][Full Text] [Related]
2. Effects of structural modifications of daunorubicin on in vitro antileukemic activity. Stojak M; Mazur L; Opydo-Chanek M; Lukawska M; Oszczapowicz I Anticancer Res; 2012 Dec; 32(12):5271-7. PubMed ID: 23225426 [TBL] [Abstract][Full Text] [Related]
3. Cell-cycle disturbance and induction of programmed death by new formamidine analogs of daunorubicin. Stojak M; Lukawska M; Oszczapowicz I; Opydo-Chanek M; Mazur L Anticancer Res; 2014 Dec; 34(12):7151-8. PubMed ID: 25503143 [TBL] [Abstract][Full Text] [Related]
4. The role of reactive oxygen species in WP 631-induced death of human ovarian cancer cells: a comparison with the effect of doxorubicin. Rogalska A; Gajek A; Szwed M; Jóźwiak Z; Marczak A Toxicol In Vitro; 2011 Dec; 25(8):1712-20. PubMed ID: 21896327 [TBL] [Abstract][Full Text] [Related]
5. Arsenic trioxide induces apoptosis in cells of MOLT-4 and its daunorubicin-resistant cell line via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3. Hu XM; Hirano T; Oka K Cancer Chemother Pharmacol; 2003 Jul; 52(1):47-58. PubMed ID: 12750841 [TBL] [Abstract][Full Text] [Related]
6. Effects of Vitamin K3 and K5 on Daunorubicin-resistant Human T Lymphoblastoid Leukemia Cells. Nakaoka E; Tanaka S; Onda K; Sugiyama K; Hirano T Anticancer Res; 2015 Nov; 35(11):6041-8. PubMed ID: 26504027 [TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity and induction of apoptosis by formamidinodoxorubicins in comparison to doxorubicin in human ovarian adenocarcinoma cells. Marczak A; Denel-Bobrowska M; Rogalska A; Łukawska M; Oszczapowicz I Environ Toxicol Pharmacol; 2015 Jan; 39(1):369-83. PubMed ID: 25561091 [TBL] [Abstract][Full Text] [Related]
8. Intrinsic and extrinsic apoptosis responses in leukaemia cells following daunorubicin treatment. Al-Aamri HM; Irving HR; Bradley C; Meehan-Andrews T BMC Cancer; 2021 Apr; 21(1):438. PubMed ID: 33879127 [TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of a phenoxazine compound, 2-amino-4,4alpha-dihydro-4alpha,7-dimethyl-3H-phenoxazine-3-one against human B cell and T cell lymphoblastoid cell lines: induction of mixed types of cell death, apoptosis, and necrosis. Koshibu-Koizumi J; Akazawa M; Iwamoto T; Takasaki M; Mizuno F; Kobayashi R; Abe A; Tomoda A; Hamatake M; Ishida R J Cancer Res Clin Oncol; 2002 Jul; 128(7):363-8. PubMed ID: 12136250 [TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide induces apoptosis equally in T lymphoblastoid leukemia MOLT-4 cells and P-gp-expressing daunorubicin-resistant MOLT-4 cells. Hu XM; Hirano T; Oka K Cancer Chemother Pharmacol; 2003 Feb; 51(2):119-26. PubMed ID: 12647012 [TBL] [Abstract][Full Text] [Related]
11. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA. Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833 [TBL] [Abstract][Full Text] [Related]
12. Biological properties of new derivatives of daunorubicin. Wasowska-Lukawska M; Wietrzyk J; Opolski A; Oszczapowicz J; Oszczapowicz I In Vivo; 2007; 21(2):413-6. PubMed ID: 17436596 [TBL] [Abstract][Full Text] [Related]
13. Drug sensitivity assay for leukaemic cells by flow cytometry. Gupta M; Naik S; Pandey CM; Dabadghao S Indian J Med Res; 2002 Jun; 115():260-4. PubMed ID: 12440199 [TBL] [Abstract][Full Text] [Related]
14. Mazur L; Opydo-Chanek M; Śladowska K; Janota B; Kłaput U; Łukawska M; Oszczapowicz I Anticancer Res; 2017 Nov; 37(11):6363-6372. PubMed ID: 29061821 [TBL] [Abstract][Full Text] [Related]
15. Comparison of Opydo-Chanek M; Śladowska K; Blicharski K; Mikeš J; Fedoročko P; Niemeyer U; Mazur L Anticancer Res; 2017 Nov; 37(11):6355-6361. PubMed ID: 29061820 [TBL] [Abstract][Full Text] [Related]
16. Characterization of cells with different mitochondrial membrane potential during apoptosis. Lugli E; Troiano L; Ferraresi R; Roat E; Prada N; Nasi M; Pinti M; Cooper EL; Cossarizza A Cytometry A; 2005 Nov; 68(1):28-35. PubMed ID: 16184612 [TBL] [Abstract][Full Text] [Related]
17. [Effects of bortezomib combined with daunorubicin on proliferation and apoptosis in primary adult acute leukemia]. Zhou RQ; Gong YP; Zheng BH; Yang X Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):789-92. PubMed ID: 21302442 [TBL] [Abstract][Full Text] [Related]
18. Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents. Pogrebniak A; Schemainda I; Azzam K; Pelka-Fleischer R; Nüssler V; Hasmann M Eur J Med Res; 2006 Aug; 11(8):313-21. PubMed ID: 17052966 [TBL] [Abstract][Full Text] [Related]
19. Caspase activation is an early event in anthracycline-induced apoptosis and allows detection of apoptotic cells before they are ingested by phagocytes. Durrieu F; Belloc F; Lacoste L; Dumain P; Chabrol J; Dachary-Prigent J; Morjani H; Boisseau MR; Reiffers J; Bernard P; Lacombe F Exp Cell Res; 1998 May; 240(2):165-75. PubMed ID: 9596989 [TBL] [Abstract][Full Text] [Related]
20. Histological Subtype of Ovarian Cancer as a Determinant of Sensitivity to Formamidine Derivatives of Doxorubicin - in Vitro Comparative Studies with SKOV-3 and ES-2 Cancer Cell Lines. Denel-Bobrowska M; Lukawska M; Oszczapowicz I; Marczak A Asian Pac J Cancer Prev; 2016; 17(9):4223-4231. PubMed ID: 27797222 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]